MyChamplainValley.com on MSN

BPD: Burlington man arrested for Battery Park assault with firearm

A 48-year-old Burlington man was arrested after taking a victims firearm, and assaulting them in the Battery Park area Sunday ...
YourTango

11 Things People With 'Quiet' Borderline Personality Disorder Secretly Struggle With

The fears of abandonment, mood swings, anxiety, self-injurious behaviors, impulsiveness, and even suicidal tendencies and ...
Morningstar

ORYZON Announces Journal Publication of Final Phase IIa REIMAGINE Results with Vafidemstat in Psychiatry and Clinical Neurosciences

The Phase IIa study REIMAGINE evaluated the safety and preliminary efficacy of vafidemstat in agitation/aggression in borderline personality disorder (BPD), attention ...
WDTN

Oryzon Defines Phase III Trial Endpoints for Agitation and Aggression in BPD with Input From New Clinical Advisory Board

Leading US psychiatric experts join Oryzon’s Clinical Advisory Board (CAB) to advance Phase III development of vafidemstat in Borderline Personality Disorder (BPD) CAB and Oryzon establish primary and ...
Psychology Today

Which Is Worse: Antagonism or Aggression?

When it comes to figuring out who to avoid, it may seem like a toss-up between antagonism and aggression, but new research ...

The differences between borderline personality disorder and bipolar, and how to recognize the symptoms of each

While borderline personality disorder and bipolar disorder share common symptoms like reckless behavior, there are a few key differences.
Morningstar

ORYZON Announces Submission of Phase III Protocol to FDA to Initiate PORTICO-2 Trial of Vafidemstat in Borderline Personality Disorder (BPD) Patients

MADRID and CAMBRIDGE, Mass., June 23, 2025 (GLOBE NEWSWIRE) -- Oryzon Genomics, S.A. (ISIN Code: ES0167733015, ORY), a clinical-stage biopharmaceutical company and a European leader in epigenetics, ...